Richeng Mao

InstitutionFudan University
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 1 publications in August 2020 and December 2020
    All Publications
    Bar chart showing 24 publications over 11 distinct years, with a maximum of 4 publications in 2010 and 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang H, Zhang Y, Wu J, Li Y, Zhou X, Li X, Chen H, Guo M, Chen S, Sun F, Mao R, Qiu C, Zhu Z, Ai J, Zhang W. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):1958-1964. PMID: 32815458.
      Citations: 35     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    2. He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol. 2021 02; 93(2):820-830. PMID: 32691881.
      Citations: 77     Fields:    Translation:Humans
    3. Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H, Ma Z, Mitra B, Zhao G, Huang Y, Guo H, Wang B, Zhang J. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog. 2019 04; 15(4):e1007690. PMID: 30998767.
      Citations: 20     Fields:    Translation:HumansCells
    4. Yu X, Zheng Y, Mao R, Su Z, Zhang J. BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection. Front Immunol. 2019; 10:617. PMID: 30984188.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    5. Guo H, Zhu B, Li S, Li J, Shen Z, Zheng Y, Zhao W, Tan D, Wu J, Zhang X, Jiang Q, Qi X, Mao R, Yu X, Su Z, Zhang J. Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. Biomed Res Int. 2019; 2019:1621627. PMID: 30937309.
      Citations:    Fields:    Translation:HumansCells
    6. Kang Y, Li F, Guo H, Yang S, Zhang Y, Zhu H, Wang J, Mao R, Qin Y, Xu J, Chen X, Wu C, Zhang J. Amino acid substitutions Q129N and T131N/M133T in hepatitis B surface antigen (HBsAg) interfere with the immunogenicity of the corresponding HBsAg or viral replication ability. Virus Res. 2018 09 15; 257:33-39. PMID: 30179704.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    7. Mani N, Cole AG, Phelps JR, Ardzinski A, Cobarrubias KD, Cuconati A, Dorsey BD, Evangelista E, Fan K, Guo F, Guo H, Guo JT, Harasym TO, Kadhim S, Kultgen SG, Lee ACH, Li AHL, Long Q, Majeski SA, Mao R, McClintock KD, Reid SP, Rijnbrand R, Snead NM, Micolochick Steuer HM, Stever K, Tang S, Wang X, Zhao Q, Sofia MJ. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation. Antimicrob Agents Chemother. 2018 06; 62(6). PMID: 29555628.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    8. Dong M, Wu J, Yu X, Li J, Yang S, Qi X, Mao R, Zhang Y, Yu J, Zhu H, Yang F, Qin Y, Zhang J. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver Int. 2018 09; 38(9):1562-1570. PMID: 29314613.
      Citations: 7     Fields:    Translation:Humans
    9. Liu Y, Nie H, Mao R, Mitra B, Cai D, Yan R, Guo JT, Block TM, Mechti N, Guo H. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog. 2017 Apr; 13(4):e1006296. PMID: 28399146.
      Citations: 38     Fields:    Translation:HumansCells
    10. Zhang Y, Mao R, Guo H, Zhang J. Detection of HBV cccDNA Methylation from Clinical Samples by Bisulfite Sequencing and Methylation-Specific PCR. Methods Mol Biol. 2017; 1540:73-84. PMID: 27975309.
      Citations: 4     Fields:    Translation:HumansCells
    11. Cai D, Wang X, Yan R, Mao R, Liu Y, Ji C, Cuconati A, Guo H. Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators. Antiviral Res. 2016 08; 132:26-37. PMID: 27185623.
      Citations: 21     Fields:    Translation:HumansCells
    12. Li X, Li F, Zhang Y, Kang Y, Yu J, Yang F, Liu H, Qin Y, Huang Y, Mao R, Zhang J. Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity. Biochem Biophys Res Commun. 2015 Sep 04; 464(4):1185-1191. PMID: 26212437.
      Citations: 1     Fields:    Translation:HumansCells
    13. Zhang Y, Mao R, Yan R, Cai D, Zhang Y, Zhu H, Kang Y, Liu H, Wang J, Qin Y, Huang Y, Guo H, Zhang J. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection. PLoS One. 2014; 9(10):e110442. PMID: 25337821.
      Citations: 35     Fields:    Translation:HumansCells
    14. Zhang Y, Zhang Y, Kang Y, Wang J, Liu H, Zhu H, Qin Y, Mao R, Lin X, Lu M, Zhang J. Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus. J Virol Methods. 2014 Jun; 201:51-6. PMID: 24583110.
      Citations: 1     Fields:    Translation:HumansCells
    15. Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013; 9(7):e1003494. PMID: 23853601.
      Citations: 96     Fields:    Translation:HumansAnimalsCells
    16. Campagna MR, Liu F, Mao R, Mills C, Cai D, Guo F, Zhao X, Ye H, Cuconati A, Guo H, Chang J, Xu X, Block TM, Guo JT. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. J Virol. 2013 Jun; 87(12):6931-42. PMID: 23576513.
      Citations: 50     Fields:    Translation:HumansAnimalsCells
    17. Zhang Y, Li C, Zhang Y, Zhu H, Kang Y, Liu H, Wang J, Qin Y, Mao R, Xie Y, Huang Y, Zhang J. Comparative analysis of CpG islands among HBV genotypes. PLoS One. 2013; 8(2):e56711. PMID: 23451072.
      Citations: 25     Fields:    Translation:Cells
    18. Lamontagne J, Mills C, Mao R, Goddard C, Cai D, Guo H, Cuconati A, Block T, Lu X. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system. Antiviral Res. 2013 Apr; 98(1):19-26. PMID: 23415884.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    19. Liu H, Mao R, Fan L, Xia J, Li Y, Yin Y, Li X, Zhao X, Guo H, Zhu H, Zhang Y, Kang Y, Zhang J. Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array. J Virol Methods. 2011 Jul; 175(1):1-6. PMID: 21513743.
      Citations: 5     Fields:    Translation:HumansCells
    20. Guo H, Pan X, Mao R, Zhang X, Wang L, Lu X, Chang J, Guo JT, Passic S, Krebs FC, Wigdahl B, Warren TK, Retterer CJ, Bavari S, Xu X, Cuconati A, Block TM. Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses. Antimicrob Agents Chemother. 2011 Feb; 55(2):478-86. PMID: 21135183.
      Citations: 26     Fields:    Translation:HumansCells
    21. Mao R, Zhang J, Jiang D, Cai D, Levy JM, Cuconati A, Block TM, Guo JT, Guo H. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol. 2011 Jan; 85(2):1048-57. PMID: 21084489.
      Citations: 58     Fields:    Translation:HumansCells
    22. Xu C, Guo H, Pan XB, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo JT. Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol. 2010 Sep; 84(18):9332-40. PMID: 20610715.
      Citations: 59     Fields:    Translation:AnimalsCells
    23. Guo H, Mao R, Block TM, Guo JT. Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses. J Virol. 2010 Jan; 84(1):387-96. PMID: 19864387.
      Citations: 73     Fields:    Translation:HumansAnimalsCells
    24. Qin Y, Zhang J, Mao R, Guo H, Yin Y, Wu X, Weng X, Wands J, Tong S. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol. 2009 May; 81(5):807-14. PMID: 19319958.
      Citations: 9     Fields:    Translation:HumansCells